KROS - Keros Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KROS is currently covered by 9 analysts with an average price target of $29.5. This is a potential upside of $14.46 (96.14%) from yesterday's end of day stock price of $15.04.

Keros Therapeutics 's activity chart (see below) currently has 52 price targets and 64 ratings on display. The stock rating distribution of KROS is 73.91% BUY and 26.09% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 41.57% with an average time for these price targets to be met of 54.92 days.

Highest price target for KROS is $26, Lowest price target is $15, average price target is $22.14.

Most recent stock forecast was given by TIAGO FAUTH from WELLS FARGO on 19-Oct-2025. First documented stock forecast 03-May-2020.

Currently out of the existing stock ratings of KROS, 17 are a BUY (73.91%), 6 are a HOLD (26.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$26

$10.96 (72.87%)

$26

6 days ago
(19-Oct-2025)

1/4 (25%)

$10.81 (71.17%)

74

Hold

$15

$-0.04 (-0.27%)

$15

4 months 26 days ago
(29-May-2025)

3/3 (100%)

$0.85 (6.01%)

70

Buy

$26

$10.96 (72.87%)

$41

5 months 14 days ago
(11-May-2025)

1/6 (16.67%)

$12.26 (89.23%)

215

Buy

$25

$9.96 (66.22%)

$40

5 months 18 days ago
(07-May-2025)

1/14 (7.14%)

$10.98 (78.32%)

113

Buy

$25

$9.96 (66.22%)

$43

6 months 17 days ago
(08-Apr-2025)

0/6 (0%)

$14.67 (142.01%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KROS (Keros Therapeutics ) average time for price targets to be met?

On average it took 54.92 days on average for the stock forecasts to be realized with a an average price target met ratio 41.57

Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?

DANIELLE BRILL

Which analyst has the most public recommendations on KROS (Keros Therapeutics )?

Danielle Brill works at TRUIST and has 7 price targets and 7 ratings on KROS

Which analyst is the currently most bullish on KROS (Keros Therapeutics )?

Tom Smith with highest potential upside - $64.96

Which analyst is the currently most reserved on KROS (Keros Therapeutics )?

Joseph Catanzaro with lowest potential downside - -$0.04

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?